Different applications for left ventricular mechanical support with the Impella Recover 100 microaxial blood pump

Andrea Garatti, Tiziano Colombo, Claudio Russo, Marco Lanfranconi, Filippo Milazzo, Emanuele Catena, Guiseppe Bruschi, Maria Frigerio, Ettore Vitali

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

The "Impella Recover 100" (IR100) is a new intravascular microaxial blood pump for use as short-term mechanical support for cases of acutely reduced left ventricular function. From September 2002 to April 2003, we used the IR100 to support 5 patients: 2 patients were bridged to heart transplant; 2 were being treated for fulminant acute myocarditis; and 1 for post-cardiotomy low-output syndrome. Only 1 patient with myocarditis died of septic shock, 2 had successful heart transplants; and the latter 2 were slowly weaned from the device and, at 3-month follow-up, showed moderate improvement of left ventricular (LV) function. Our initial experience with the IR100 as mechanical support for patients in cardiogenic shock of varying etiology has been positive, yielding good survival in a population of particularly compromised patients.

Original languageEnglish
Pages (from-to)481-485
Number of pages5
JournalJournal of Heart and Lung Transplantation
Volume24
Issue number4
DOIs
Publication statusPublished - Apr 2005

Fingerprint

Myocarditis
Left Ventricular Function
Transplants
Cardiogenic Shock
Septic Shock
Equipment and Supplies
Survival
Population

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Transplantation

Cite this

Different applications for left ventricular mechanical support with the Impella Recover 100 microaxial blood pump. / Garatti, Andrea; Colombo, Tiziano; Russo, Claudio; Lanfranconi, Marco; Milazzo, Filippo; Catena, Emanuele; Bruschi, Guiseppe; Frigerio, Maria; Vitali, Ettore.

In: Journal of Heart and Lung Transplantation, Vol. 24, No. 4, 04.2005, p. 481-485.

Research output: Contribution to journalArticle

Garatti, A, Colombo, T, Russo, C, Lanfranconi, M, Milazzo, F, Catena, E, Bruschi, G, Frigerio, M & Vitali, E 2005, 'Different applications for left ventricular mechanical support with the Impella Recover 100 microaxial blood pump', Journal of Heart and Lung Transplantation, vol. 24, no. 4, pp. 481-485. https://doi.org/10.1016/j.healun.2004.02.002
Garatti, Andrea ; Colombo, Tiziano ; Russo, Claudio ; Lanfranconi, Marco ; Milazzo, Filippo ; Catena, Emanuele ; Bruschi, Guiseppe ; Frigerio, Maria ; Vitali, Ettore. / Different applications for left ventricular mechanical support with the Impella Recover 100 microaxial blood pump. In: Journal of Heart and Lung Transplantation. 2005 ; Vol. 24, No. 4. pp. 481-485.
@article{4f3ba081035f4595930f178fe6cd3496,
title = "Different applications for left ventricular mechanical support with the Impella Recover 100 microaxial blood pump",
abstract = "The {"}Impella Recover 100{"} (IR100) is a new intravascular microaxial blood pump for use as short-term mechanical support for cases of acutely reduced left ventricular function. From September 2002 to April 2003, we used the IR100 to support 5 patients: 2 patients were bridged to heart transplant; 2 were being treated for fulminant acute myocarditis; and 1 for post-cardiotomy low-output syndrome. Only 1 patient with myocarditis died of septic shock, 2 had successful heart transplants; and the latter 2 were slowly weaned from the device and, at 3-month follow-up, showed moderate improvement of left ventricular (LV) function. Our initial experience with the IR100 as mechanical support for patients in cardiogenic shock of varying etiology has been positive, yielding good survival in a population of particularly compromised patients.",
author = "Andrea Garatti and Tiziano Colombo and Claudio Russo and Marco Lanfranconi and Filippo Milazzo and Emanuele Catena and Guiseppe Bruschi and Maria Frigerio and Ettore Vitali",
year = "2005",
month = "4",
doi = "10.1016/j.healun.2004.02.002",
language = "English",
volume = "24",
pages = "481--485",
journal = "Journal of Heart and Lung Transplantation",
issn = "1053-2498",
publisher = "Elsevier USA",
number = "4",

}

TY - JOUR

T1 - Different applications for left ventricular mechanical support with the Impella Recover 100 microaxial blood pump

AU - Garatti, Andrea

AU - Colombo, Tiziano

AU - Russo, Claudio

AU - Lanfranconi, Marco

AU - Milazzo, Filippo

AU - Catena, Emanuele

AU - Bruschi, Guiseppe

AU - Frigerio, Maria

AU - Vitali, Ettore

PY - 2005/4

Y1 - 2005/4

N2 - The "Impella Recover 100" (IR100) is a new intravascular microaxial blood pump for use as short-term mechanical support for cases of acutely reduced left ventricular function. From September 2002 to April 2003, we used the IR100 to support 5 patients: 2 patients were bridged to heart transplant; 2 were being treated for fulminant acute myocarditis; and 1 for post-cardiotomy low-output syndrome. Only 1 patient with myocarditis died of septic shock, 2 had successful heart transplants; and the latter 2 were slowly weaned from the device and, at 3-month follow-up, showed moderate improvement of left ventricular (LV) function. Our initial experience with the IR100 as mechanical support for patients in cardiogenic shock of varying etiology has been positive, yielding good survival in a population of particularly compromised patients.

AB - The "Impella Recover 100" (IR100) is a new intravascular microaxial blood pump for use as short-term mechanical support for cases of acutely reduced left ventricular function. From September 2002 to April 2003, we used the IR100 to support 5 patients: 2 patients were bridged to heart transplant; 2 were being treated for fulminant acute myocarditis; and 1 for post-cardiotomy low-output syndrome. Only 1 patient with myocarditis died of septic shock, 2 had successful heart transplants; and the latter 2 were slowly weaned from the device and, at 3-month follow-up, showed moderate improvement of left ventricular (LV) function. Our initial experience with the IR100 as mechanical support for patients in cardiogenic shock of varying etiology has been positive, yielding good survival in a population of particularly compromised patients.

UR - http://www.scopus.com/inward/record.url?scp=15544384714&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15544384714&partnerID=8YFLogxK

U2 - 10.1016/j.healun.2004.02.002

DO - 10.1016/j.healun.2004.02.002

M3 - Article

C2 - 15797752

AN - SCOPUS:15544384714

VL - 24

SP - 481

EP - 485

JO - Journal of Heart and Lung Transplantation

JF - Journal of Heart and Lung Transplantation

SN - 1053-2498

IS - 4

ER -